Part 6
Appendices and Evidence (Part 2)
Matrix of Contradictions
(2018 Specialist Report vs 2026 Routine Sight Test)
|
Clinical Feature
|
Report 2018 vs Letter 2026
|
Clinical Concern
|
| Nystagmus |
2018: Permanent vertical nystagmus. 2026: Described as “intermittent.”
|
Neurological Nystagmus Cannot be intermittent |
| Eye Movement |
2018: Very poor control; Severe neurological impairment.
2026: Not mentioned.
|
Major neurological feature omitted |
| Diplopia |
2018: Intractable double vision; no suppression
2026: Not mentioned
|
Critical neurological feature omitted. |
| Strabismus |
2018: Divergent strabismus; unstable fixation.
2026: Alternating exotropia.
|
Conflicting findings; neurological vs ocular interpretation. |
| Spatial Awareness |
2018: Extremely poor spatial perception.
2026: Not assessed.
|
Functional‑vision risk ignored. |
| Functional Vision |
2018: Difficulty in crowds, traffic, low light.
2026: Only “difficulty in low light.” |
2018: No change since 1994; permanent impairment.
2026: “Eyes remain stable” (refers only to short‑sight).
|
| Baseline Stability |
2018: No change since 1994; permanent impairment.
2026: “Eyes remain stable” (refers only to short‑sight).
|
Refractive stability ≠ neurological stability. |
| Clinical Framework |
2018: Neuro‑ophthalmology; neurological assessment.
2026: Routine optometry; ocular framework only.
|
Wrong framework applied to a neurological condition |
Closing Summary for Part 6 — Appendices & Evidence
Part 6 brings together the full body of clinical, functional‑vision, and historical evidence spanning more than three decades. Across all sources — specialist neuro‑visual reports, long‑term clinical records, functional‑vision assessments, and continuity‑of‑care documentation — the picture is clear, consistent, and stable.
The young person’s neurological visual impairment has remained unchanged since the early 1990s. Every specialist review has reaffirmed the same core features: permanent vertical nystagmus, severely impaired eye‑movement control, divergent strabismus, intractable diplopia, and extremely poor spatial perception. These findings form a long‑standing clinical baseline that has never been contradicted by any qualified specialist.
The only deviation in the entire 33‑year record is the 2026 routine sight‑test letter. This assessment used an ocular framework instead of a neurological one, omitted essential tests, introduced clinically inconsistent terminology, and failed to reference the established baseline. The Matrix of Contradictions demonstrates that the 2026 conclusions cannot be reconciled with the specialist evidence and therefore cannot be relied upon.
Taken together, the evidence in Part 6 shows:
- the impairment is permanent and neurological
- the clinical picture has remained stable for over three decades
- functional‑vision risks have been consistently documented
- the 2026 routine sight test represents a break in continuity of care
- the specialist evidence remains the authoritative baseline
Part 6 therefore establishes a clear, evidence‑based foundation for understanding the young person’s visual impairment and the concerns that arise when established neurological findings are not recognised or carried forward.
The next part examines how these contradictions entered the record, how they were handled, and the wider governance issues that followed.
Next
Part 7 — Governance Concerns & Continuity Failures
Design & Copyright Owner Maureen Booth-Martin (MBM) © All rights reserved
| Visitor Counter: | |||||||
 |  |  | |  | | ||